Repositori Institucional UIB
Publicación
Artículo científico (JournalArticle)
Dietary folate intake and metabolic syndrome in participants of PREDIMED-Plus study: a cross-sectional study
[eng] Purpose: We examined the association between dietary folate intake and a score of MetS (metabolic syndrome) and its components among older adults at higher cardiometabolic risk participating in the PREDIMED-Plus trial. Methods: A cross-sectional analysis with 6633 with overweight/obesity participants with MetS was conducted. Folate intake (per 100 mcg/day and in quintiles) was estimated using a validated food frequency questionnaire. We calculated a MetS score using the standardized values as shown in the formula: [(body mass index+waist-to-height ratio)/2]+[(systolic blood pressure+diastolic blood pressure)/2]+plasma fasting glucose–HDL cholesterol+plasma triglycerides. The MetS score as continuous variable and its seven components were the outcome variables. Multiple robust linear regression using MM-type estimator was performed to evaluate the association adjusting for potential confounders. Results: We observed that an increase in energy-adjusted folate intake was associated with a reduction of MetS score (β for 100 mcg/day=− 0.12; 95% CI: − 0.19 to − 0.05), and plasma fasting glucose (β=− 0.03; 95% CI: − 0.05 to − 0.02) independently of the adherence to Mediterranean diet and other potential confounders. We also found a positive association with HDL-cholesterol (β=0.07; 95% CI: 0.04–0.10). These associations were also observed when quintiles of energy-adjusted folate intake were used instead. Conclusion: This study suggests that a higher folate intake may be associated with a lower MetS score in older adults, a lower plasma fasting glucose, and a greater HDL cholesterol in high-risk cardio-metabolic subjects
Proyecto:
ISCIII / Advanced Research Grant 2013–2018 PI13
,
ISCIII / 2013ACUP00194 PI13
,
ISCIII / Long-term effects of an energy-restricted Mediterranean diet on mortality and cardiovascular disease 2014–2015 PI13
,
ISCIII / Grant of support to research groups PI13
,
ISCIII PI13
,
ISCIII PI13
,
ISCIII PI13
,
ISCIII PI13
,
ISCIII PI13
,
ISCIII PI13
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI14
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI16
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
ISCIII PI17
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI13
,
FEDER PI14
,
FEDER PI14
,
FEDER PI14
,
FEDER PI14
,
FEDER PI14
,
FEDER PI14
,
FEDER PI14
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI16
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
FEDER PI17
,
ERC 340918
,
Recercaixa [ES]
,
SAS PI0458
,
SAS PS0358
,
SAS PI0137
,
GVA PROMETEO
,
SEMERGEN CB06
,
SEMERGEN CB12
,
FEDER CB06
,
FEDER CB12
,
FESNAD 201302
,
GOIB 35